Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026
The most important clinical decision with Neuropathic Foot Pain: Causes, Best Medications, and Treatment Options isn’t which treatment to choose — it’s identifying which subtype you have first. Our podiatrists see patients treated for the wrong subtype for months before the correct diagnosis leads to full resolution. Call (810) 206-1402 — expert podiatric care across Michigan.
| Medication Class | Examples | Mechanism | NNT (Neuropathic Pain) | Common Side Effects |
|---|---|---|---|---|
| Gabapentinoids | Gabapentin (Neurontin); Pregabalin (Lyrica) | Alpha-2-delta calcium channel subunit blockade; reduces excitatory neurotransmission | 3.9 (gabapentin); 4.9 (pregabalin) | Sedation; dizziness; weight gain; edema; abuse potential (pregabalin Schedule V) |
| SNRIs | Duloxetine (Cymbalta); Venlafaxine | Serotonin-norepinephrine reuptake inhibition; modulates descending pain inhibition | 6.4 (duloxetine); 5.5 (venlafaxine) | Nausea; insomnia; dry mouth; hypertension (venlafaxine higher dose) |
| TCAs | Amitriptyline; Nortriptyline | Norepinephrine/serotonin reuptake inhibition; Na channel blockade; oldest NP drug | 3.6 (amitriptyline) | Anticholinergic: dry mouth, constipation, urinary retention; sedation; cardiac arrhythmia risk at higher doses |
| Topical lidocaine (5%) | Lidocaine patch (Lidoderm) | Na channel blockade; focal analgesia without systemic effects | 4.4 | Local skin reactions; minimal systemic (negligible absorption) |
| Topical capsaicin (8%) | Qutenza patch (prescription) | TRPV1 agonist; depletes substance P from nociceptors | 10.6 | Severe burning during application (requires pretreatment); lasts 12 weeks per application |
| Tramadol | Tramadol (Ultram) | Weak opioid + SNRI mechanism; Schedule IV | 4.4 | Nausea; dizziness; seizure risk; serotonin syndrome risk; abuse potential |
| Opioids (strong) | Oxycodone; Morphine | Mu opioid receptor agonism | 4.3 | Constipation; sedation; dependence; addiction; overdose risk; not recommended first-line |
| Non-Pharmacological Treatment | Evidence | How It Works | Practical Notes |
|---|---|---|---|
| Transcutaneous electrical nerve stimulation (TENS) | Moderate | Gate control theory; activates Abeta fibers to inhibit C-fiber pain transmission | Home TENS units; 30–60 min sessions; most effective for localized neuropathic pain |
| Spinal cord stimulation (SCS) | Strong for refractory cases | Dorsal horn inhibition via electrical field; dorsal column stimulation | Implanted device; specialist-managed; 50–70% responders for painful diabetic neuropathy |
| Scrambler therapy (MC5-A) | Moderate — emerging | Delivers “non-pain” electrical signal via surface electrodes; retrains pain pathways | Series of 10 daily sessions; significant pain reduction in clinical studies |
| Low-level laser therapy (LLLT) | Moderate for DPN | Photobiomodulation; mitochondrial activation; nerve fiber regeneration | MLS laser available at Balance Foot & Ankle; series of treatments |
| Acupuncture | Moderate | Endorphin release; descending inhibitory pathway activation | Multiple sessions required; most beneficial for musculoskeletal component |
| Physical therapy / balance training | Strong for functional outcomes | Proprioception compensation; fall risk reduction; gait retraining | Does not reduce pain directly; critical for safety and function |
Neuropathic Pain in the Foot: Why It Feels Different
Neuropathic pain in the foot — burning, electric shock-like sensations, allodynia (pain from light touch that shouldn’t hurt), and the paradox of numbness coexisting with pain — is mechanistically different from nociceptive (tissue damage) pain and requires a completely different treatment approach. Standard pain medications (NSAIDs, acetaminophen) have little effect on neuropathic pain because the pain isn’t driven by inflammation or tissue injury signals: it’s driven by abnormal firing of damaged or malfunctioning peripheral nerves and sensitized central pain pathways. This is why patients with diabetic peripheral neuropathy often get minimal relief from ibuprofen while responding well to gabapentin or duloxetine.
Common Causes of Neuropathic Foot Pain
Diabetic peripheral neuropathy (DPN) is the most prevalent cause, affecting approximately 50% of people with diabetes over their lifetime. The mechanism: chronic hyperglycemia damages the vasa nervorum (tiny blood vessels supplying peripheral nerves), causing ischemic injury to the axons and myelin sheath. DPN typically begins in the longest nerves first — the toes and forefoot — producing the classic stocking-glove distribution. Symptoms range from burning, tingling, and electric pain in early stages to profound numbness with loss of protective sensation in advanced stages. Paradoxically, the most dangerous stage of DPN is painless: complete loss of sensation eliminates the warning signals that prevent injury.
Other causes of neuropathic foot pain include: tarsal tunnel syndrome (tibial nerve compression at the medial ankle, producing burning and tingling in the plantar foot); Morton’s neuroma (interdigital nerve compression producing webspace burning and electric shocks with weight-bearing); Charcot-Marie-Tooth disease (hereditary progressive peripheral neuropathy); post-herpetic neuralgia after herpes zoster in the foot; small fiber neuropathy (affects only small pain and temperature fibers; normal nerve conduction studies; diagnosed by skin punch biopsy for intraepidermal nerve fiber density); and complex regional pain syndrome (CRPS) following foot or ankle injury or surgery.
Medication Approach: Evidence-Based First-Line Options
The FDA has approved duloxetine (SNRI) and pregabalin for diabetic peripheral neuropathy. Gabapentin (similar mechanism to pregabalin, lower abuse potential, not FDA-approved for DPN but widely used off-label) is equally effective in practice. Tricyclic antidepressants (amitriptyline, nortriptyline at 10–75mg at bedtime) have the best number-needed-to-treat among oral agents but are limited by anticholinergic side effects, particularly in elderly patients. Topical agents — lidocaine 5% patch and capsaicin 8% patch (Qutenza) — provide focal analgesia without systemic side effects, making them useful for patients with multiple drug interactions or intolerance to oral agents. No single agent controls neuropathic pain in all patients; combination approaches (e.g., gabapentin + duloxetine) achieve better analgesia than maximizing either drug alone.
At Balance Foot & Ankle, Dr. Tom Biernacki and Dr. Carl Jay provide neuropathic pain evaluation, MLS laser therapy, and diabetic neuropathy management at both the Howell and Bloomfield Hills offices. Call (810) 206-1402.
American Podiatric Medical Association: Neuropathic Pain
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
For a complete clinical overview: Foot Neuropathy Treatment Guide — peripheral neuropathy causes and all treatment options
What does foot neuropathy feel like?
Burning, tingling, numbness, or shooting pain — often worse at night. Balance problems and hypersensitivity to touch are also common.
Can foot neuropathy improve?
B12 deficiency neuropathy reverses with supplementation. Diabetic neuropathy slows with tight blood sugar control. Medications like gabapentin manage pain symptoms effectively.
Doctor Answer
What is neuropathic pain in the foot and how is it treated?
Neuropathic foot pain results from nerve damage — commonly due to diabetes, peripheral neuropathy, tarsal tunnel syndrome, or Morton’s neuroma — causing burning, shooting, or tingling sensations. Treatment includes managing the underlying condition, medications such as gabapentin or duloxetine, topical agents, custom orthotics, and in some cases nerve blocks or surgery. A podiatrist works alongside neurologists and primary care physicians for comprehensive management.
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.